Baxter and XOMA Enter Agreement for NEUPREX in Meningococcemia and Related Future Indications.
Business Editors and Health/Medical Writers
DEERFIELD, Ill./BERKELEY, Calif.--(BW HealthWire)--Jan. 24, 2000 Baxter Healthcare Corporation (NYSE: BAX) and XOMA Ltd. (Nasdaq: XOMA) announced today an agreement in which Baxter's Hyland Immuno division has acquired the world...
Try vLex for FREE for 3 days
Access legal information from United States including:
Constitutions
Forms and Contracts
Legal Books and Journals
Case Law
News and Business
Regulations
U.S. Code
Try vLex without any commitment for 3 days and see why you need it.